CPIX Earnings
Latest Revenue2.2M
Latest Net Income77.8M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q3 2026 | $5.19 | 2.2M | 77.8M | +1,155.0% | +4,092.3% |
| Q2 2026 | -$0.29 | 166.5K | -4274430 | -56.3% | -480.0% |
| Q1 2026 | -$0.22 | 9.1M | -3287051 | -22.0% | -375.0% |
| Q4 2025 | -$0.10 | 13.7M | -1428642 | +31.1% | +28.6% |
| Q3 2025 | -$0.13 | 171.8K | -1949046 | -98.1% | -18.2% |
| Q2 2025 | -$0.05 | 380.8K | -735207 | -96.1% | +37.5% |
| Q1 2025 | $0.08 | 11.7M | 1.2M | +37.8% | +157.1% |
| Q4 2024 | -$0.14 | 10.4M | -1901637 | +11.6% | +68.2% |
| Q3 2024 | -$0.11 | 9.1M | -1536969 | — | — |
| Q2 2024 | -$0.08 | 9.8M | -1102637 | — | — |
| Q1 2024 | -$0.14 | 8.5M | -1902472 | — | — |
| Q4 2023 | -$0.44 | 9.4M | -6301987 | — | — |
Cumberland Pharmaceuticals (CPIX) — Earnings